Table 1.
All patients | Thyroid disease status | Celiac disease status | ||||
---|---|---|---|---|---|---|
No thyroid disease | Autoantibodies + normal TSH (T1D + AB, untreated) | Autoantibodies + high TSH upon diagnosis (T1D + AITD, treated) |
No celiac disease | Celiac disease (T1D + CD) | ||
n | 248 | 143 (57.6%) | 65 (26.2%) | 40 (16.1%) | 222 (89.5%) | 26 (10.5%) |
| ||||||
Females (n, %) | 118 (47.6%) | 63 (44.0%) | 27 (41.5%) | 28 (70.0%)a | 104 (46.8%) | 14 (53.8%) |
Age (years) | 13.7 (11.6–16.6) | 13.3 (11.3–16.0) | 14.0 (10.9–16.7) | 15.2 (13.2–17.2)b | 13.4 (11.7–13.9) | 13.4 (11.7–13.9) |
T1D treatment | ||||||
Insulin pen | 156 | 90 | 39 | 27 | 142 | 14 |
Insulin pump | 96 (38.7%) | 53 (37.0%) | 26 (40.0%) | 13 (32.5%) | 80 (36.0%) | 12 (46.1%) |
HbA1c (mmol/mol IFCC) | 68 (60–77) | 67 (60–75) | 66 (60–76) | 75 (63–82)c | 68 (60–77) | 72 (60–83) |
Diabetes duration (years) | 6.3 (3.0–9.3) | 5.8 (2.8–9.3) | 5.7 (2.8–8.8) | 7.8 (5.2–10.6) | 5.9 (2.8–9.3) | 7.6 (4.9–9.1) |
Data are described as median (interquartile range) or n (%).
a P = 0.0065 as compared to subjects with no thyroid disease; b P = 0.0017 as compared to subjects with no thyroid disease; c P = 0.044 as compared to subjects with no thyroid disease.